Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Hilleman Labs successfully completes phase I/II clinical trial of oral cholera vaccine Hillchol

expressbpdOctober 17, 2017

Tag: Hilleman Labs , cholera vaccine , Hillchol

PharmaSources Customer Service